Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Not all investors can use a backdoor Roth. This intro clarifies eligibility and the basic implementation steps.
27,669 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Solana Foundation rolled out an AI agent thesis at a major New York summit, arguing a platform shift could redraw Sol...
Tower Semiconductor is navigating a critical inflection point as it scales SiPho production and expands in Japan, wit...
A popular long-duration corporate bond ETF is attracting fresh attention as rate bets shift. Investors are weighing t...
As factories re-shore production in 2026, three ETFs track the trend with different tilts. Here is how AIRR, PAVE, an...
Apple reports strong Q2 2026 results, led by iPhone demand and Services, while signaling a shift toward ambient AI th...
Costco just posted strong Q2 FY26 results, fueling a bullish one-year outlook. This article breaks down the data, gro...
A private Dallas developer secures a government-backed funding package to build a Gulf of Mexico deepwater oil termin...
Lumentum’s fiery stock rally this year has propelled the optics company into the top tier of the market, signaling a ...
Bitcoin and XRP led a crypto rally after a Trump Iran-focused post, with BTC moving higher and XRP testing multi-week...
Kim Hoffman unveils an AI-powered risk platform as she champions hoffman leadership and the idea of pushing beyond se...
A new White House mascot, meet ‘coalie,’ anime-style anthropomorphic coal, is shaping how investors view energy polic...